In non-ischemic cardiomyopathy, which imaging modality is best for detecting late gadolinium enhancement patterns indicative of fibrosis?

• A. CMR
• B. Echocardiography
• C. CT
• D. Nuclear Imaging

Answer: (A)

The main idea is that cardiac MRI with gadolinium contrast, using late gadolinium enhancement imaging, is the most effective way to detect myocardial fibrosis patterns in non-ischemic cardiomyopathy. Gadolinium accumulates where the extracellular space is expanded, as in fibrotic tissue, so fibrosis shows up as bright (hyperenhanced) areas on T1-weighted MRI images. In non-ischemic disease, these fibrotic patterns are typically mid-wall or subepicardial rather than subendocardial/transmural, which helps distinguish them from scar due to ischemia. Cardiac MRI offers superior tissue characterization and high spatial resolution, making it the best choice for identifying and characterizing fibrosis. Other imaging modalities can assess structure or function or visualize scar, but they don’t match MRI’s combination of detailed tissue contrast and precise pattern recognition, and some involve radiation or contrast limitations.